A Literature Analysis of Prognostic Factors for Response and Quality of Response of Patients with Renal Cell Carcinoma to Interleukin-2-Based Therapy

Publisher： Karger

E-ISSN： 1423-0232|61|2|91-101

ISSN： 0030-2414

Source： Oncology, Vol.61, Iss.2, 2001-08, pp. : 91-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin‐ 28B: a prognostic marker in interferon based therapy of chronic HCV patients of the Pakistan with variable treatment response

By  

APMIS (ELECTRONIC), Vol. 123, Iss. 9, 2015-09 ,pp. : 765-771

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gemcitabine Monotherapy as Second-Line Treatment in Cisplatin-Refractory Transitional Cell Carcinoma – Prognostic Factors for Response and Improvement of Quality of Life

By  

Oncology Research and Treatment, Vol. 25, Iss. 1, 2002-03 ,pp. : 47-52

Karger

Access to resources Recommend Favorite

Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 919-8172, Iss. 10, 2015-10 ,pp. : 888-897

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 10, 2015-10 ,pp. : 888-897

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intraobserver and interobserver variability in computed tomography size and attenuation measurements in patients with renal cell carcinoma receiving antiangiogenic therapy: Implications for alternative response criteria

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 711-721

John Wiley & Sons Inc

Access to resources Recommend Favorite